The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
The role of aldehyde oxidase in drug metabolism
Abstract
INTRODUCTION: Aldehyde oxidases (AOXs) are molybdo-flavoenzymes with complex evolutionary profiles, as the number and types of active AOX genes vary according to the animal species considered. Humans and higher primates have a single functional AOX1 gene, while rodents are endowed with four AOXs. Along with the endoplasmic cytochrome P450 system (CYP450), cytoplasmic AOX1 is the major enzyme involved in the hepatic phase I metabolism of numerous xenobiotics. AREAS COVERED: The authors review literature to highlight the fact that aldehydes are not the only AOX substrates, as aza- and oxo-heterocycles, that represent the scaffold of many drugs, are also oxidized efficiently by these enzymes. Additionally, the ndefine the different complements of AOX isoenzymes expressed in humans and animal models used in drug metabolism studies and discuss the implications. Furthermore, the authors report on human AOX1 allelic variants that alter the activity of this enzyme. Finally, they discuss the factors of potential importance in controlling the functional activity of AOX1. EXPERT OPINION: There is evidence for an increasing relevance of AOX1 in the metabolism and clearance of new drugs, as measures aiming at controlling CYP450-dependent metabolism of prospective therapeutic agents are becoming routine. This calls for investigations into the biology, catalytic properties and substrate specificity of human AOX1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the function of AO in mammals is yet to be established (434, 935), AO appears to play an important role in drug metabolism and other metabolic pathways (335, 512, 513, 756, 920).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [335]
Citations
Cites
Enroth, C., Eger, B. T., Okamoto, K., Nishino, T., Nishino, T., & Pai, E. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10723 · Cited by 733
Molybdenum and tungsten in biology
Hille, R. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02107-2 · Cited by 439
Nishino, T., Okamoto, K., Eger, B. T., PAI, E. F., & Nishino, T. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06489.x · Cited by 397
Aldehyde Oxidase: An Enzyme of Emerging Importance in Drug Discovery
Pryde, D. C., Dalvie, D., Hu, Q., Jones, P., Obach, R. S., & Tran, T.-D. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100888d · Cited by 350
Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2* activities
Relling, M. V., Lin, J., Ayers, G. D., & Evans, W. E. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.203 · Cited by 314
Garattini, E., Mendel, R. R., Romão, M. J., Wright, R. M., & Terao, M. (2003) · Biochemical Journal · doi:10.1042/bj20030121 · Cited by 241
Self-citationHuman Liver Aldehyde Oxidase: Inhibition by 239 Drugs
Obach, R. S., Huynh, P. T., Allen, M. C., & Beedham, C. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003260336 · Cited by 224
Drug-Metabolizing Ability of Molybdenum Hydroxylases
Kitamura, S., Sugihara, K., & Ohta, S. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.83 · Cited by 216
Mammalian aldehyde oxidases: genetics, evolution and biochemistry
Garattini, E., Fratelli, M., & Terao, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7398-y · Cited by 188
Self-citationPOTENT INHIBITION OF HUMAN LIVER ALDEHYDE OXIDASE BY RALOXIFENE
Obach, R. S. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.1.89 · Cited by 168
Research works printed but not linked: 6
- Beedham C, 2003, J Clin Psychopharmacol, 23, 229
- Rashidi MR, 1997, Drug Metab Dispos, 25, 805
- Sanoh S, 2011, Drug Metab Dispos
- Panoutsopoulos GI, 2004, In Vivo, 18, 779
- Sugihara K, 1997, Biochem Mol Biol Int, 41, 1153
- Kinsella TJ, 2000, Clin Cancer Res, 6, 3670
Cited by
Sorted by citations
Modern advances in heterocyclic chemistry in drug discovery
Taylor, A. P., Robinson, R. P., Fobian, Y. M., Blakemore, D. C., Jones, L. H., & Fadeyi, O. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob00936k · Cited by 903
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
Fan, J., & de Lannoy, I. A. M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.09.007 · Cited by 309
The role of drug metabolizing enzymes in clearance
Di, L. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.876006 · Cited by 216
Laskar, A. A., & Younus, H. (2018) · Drug Metabolism Reviews · doi:10.1080/03602532.2018.1555587 · Cited by 202
Lai, Y., Chu, X., Di, L., Gao, W., Guo, Y., Liu, X., Lu, C., Mao, J., Shen, H., Tang, H., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.03.009 · Cited by 182
Chi, Y.-O., Li, L., Xu-Monette, Z. Y., Visco, C., Tzankov, A., Manyam, G., Montes-Moreno, S., Dybkær, K., Chiu, A., Orazi, A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3157 · Cited by 134
Comparison of minipig, dog, monkey and human drug metabolism and disposition
Dalgaard, L. (2015) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2014.12.005 · Cited by 132
Ichida, K., Amaya, Y., Okamoto, K., & Nishino, T. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131115475 · Cited by 121
Foti, R., & Dalvie, D. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.071753 · Cited by 118
Structure and function of mammalian aldehyde oxidases
Terao, M., Romão, M. J., Leimkühler, S., Bolis, M., Fratelli, M., Coelho, C., Santos-Silva, T., & Garattini, E. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1683-1 · Cited by 112
Self-citationKumar, R., Joshi, G., Kler, H., Kalra, S., Kaur, M., & Arya, R. (2017) · Medicinal Research Reviews · doi:10.1002/med.21457 · Cited by 107
Diao, X., & HUESTIS, M. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.534 · Cited by 104
Strategies for a comprehensive understanding of metabolism by aldehyde oxidase
Hutzler, J. M., Obach, R. S., Dalvie, D., & Zientek, M. A. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.738668 · Cited by 96
Skin metabolism phase I and phase II enzymes in native and reconstructed human skin: a short review
Kazem, S., Linssen, E. C., & Gibbs, S. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.06.002 · Cited by 98
Structural insights into xenobiotic and inhibitor binding to human aldehyde oxidase
Coelho, C., Foti, A., Hartmann, T., Santos‐Silva, T., Leimkühler, S., & Romão, M. J. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1895 · Cited by 92
Argikar, U. A., Potter, P. M., Hutzler, J. M., & Marathe, P. H. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9962-6 · Cited by 89
Aldehyde oxidase and its role as a drug metabolizing enzyme
Dalvie, D., & Di, L. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.011 · Cited by 91
Clinical Pharmacokinetic and Pharmacodynamic Profile of Idelalisib
Ramanathan, S., Jin, F., Sharma, S., & Kearney, B. P. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0304-0 · Cited by 84
Villamena, F. A., Das, A. K., & Nash, K. M. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.74 · Cited by 85
Sanoh, S., Tayama, Y., Sugihara, K., Kitamura, S., & Ohta, S. (2014) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2014.10.009 · Cited by 76
Strelevitz, T. J., Orozco, C. C., & Obach, R. S. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.045195 · Cited by 77
Nitrite‐dependent nitric oxide synthesis by molybdenum enzymes
Bender, D. A., & Schwarz, G. (2018) · FEBS Letters · doi:10.1002/1873-3468.13089 · Cited by 76
Evolution, expression, and substrate specificities of aldehyde oxidase enzymes in eukaryotes
Terao, M., Garattini, E., Romão, M. J., & Leimkühler, S. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.007741 · Cited by 76
Self-citationMolybdenum’s Role as an Essential Element in Enzymes Catabolizing Redox Reactions: A Review
Adamus, J. P., Ruszczyńska, A., & Wyczałkowska-Tomasik, A. (2024) · Biomolecules · doi:10.3390/biom14070869 · Cited by 68
Aldehyde oxidase and its importance in novel drug discovery: present and future challenges
Garattini, E., & Terao, M. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.788497 · Cited by 68
Self-citationGlaenzel, U., Jin, Y., Hansen, R., Schroer, K., Rahmanzadeh, G., Pfaar, U., van Lier, J. J., Borell, H., Meissner, A., Camenisch, G., et al. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.090324 · Cited by 63
Structure and evolution of vertebrate aldehyde oxidases: from gene duplication to gene suppression
Kurosaki, M., Bolis, M., Fratelli, M., Barzago, M. M., Pattini, L., Perretta, G., Terao, M., & Garattini, E. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1229-5 · Cited by 61
Self-citationGalactose Oxidase Variants for the Oxidation of Amino Alcohols in Enzyme Cascade Synthesis
Herter, S., McKenna, S. M., Frazer, A. R., Leimkühler, S., Carnell, A. J., & Turner, N. J. (2015) · ChemCatChem · doi:10.1002/cctc.201500218 · Cited by 62
Zheng, J., Xin, Y., Zhang, J., Subramanian, R., Murray, B. P., Whitney, J. A., Warr, M. R., Ling, J. R., Moorehead, L., Kwan, E., et al. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.078899 · Cited by 61
Ehteshami, M., Rasoulzadeh, F., Mahboob, S., & Rashidi, M. (2012) · Journal of Luminescence · doi:10.1016/j.jlumin.2012.10.044 · Cited by 59
Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue
Geybels, M. S., Zhao, S., Wong, C.-J., Bibikova, M. V., Klotzle, B., Wu, M. C., Ostrander, E. A., Fan, J., Feng, Z., & Stanford, J. L. (2015) · The Prostate · doi:10.1002/pros.23093 · Cited by 60
A Simple Litmus Test for Aldehyde Oxidase Metabolism of Heteroarenes
O’Hara, F., Burns, A. C., Collins, M. R., Dalvie, D., Ornelas, M. A., Vaz, A. D. N., Fujiwara, Y., & Baran, P. S. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4017976 · Cited by 53
Aldehyde Oxidase: Reaction Mechanism and Prediction of Site of Metabolism
Montefiori, M., Jørgensen, F. S., & Olsen, L. (2017) · ACS Omega · doi:10.1021/acsomega.7b00658 · Cited by 51
Interspecies variation in the metabolism of zoniporide by aldehyde oxidase
Dalvie, D., Xiang, C. D., Kang, P., & Zhou, S. (2012) · Xenobiotica · doi:10.3109/00498254.2012.727499 · Cited by 47
Cruciani, G., Milani, N., Benedetti, P., Lepri, S., Cesarini, L., Baroni, M., Spyrakis, F., Tortorella, S., Mosconi, E., & Goracci, L. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01552 · Cited by 46
Hutzler, J. M., Yang, Y.-S., Brown, C., Heyward, S. A., & Moeller, T. A. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.057984 · Cited by 46
Martinez, M. N., Mochel, J. P., Neuhoff, S., & Pade, D. (2021) · The AAPS Journal · doi:10.1208/s12248-021-00590-0 · Cited by 48
Hip To Be Square: Oxetanes as Design Elements To Alter Metabolic Pathways
Toselli, F., Fredenwall, M., Svensson, P., Li, X., Johansson, A., Weidolf, L. O. G., & Hayes, M. A. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00030 · Cited by 43
Morrison, R. D., Blobaum, A. L., Byers, F. W., Santomango, T. S., Bridges, T. M., Stec, D. F., Brewer, K. A., Sánchez-Ponce, R., Corlew, M. M., Rush, R., et al. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.046136 · Cited by 42
Evidence for Substrate-Dependent Inhibition Profiles for Human Liver Aldehyde Oxidase
Barr, J., & Jones, J. P. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.048546 · Cited by 42
Choughule, K. V., Barnaba, C., Joswig-Jones, C. A., & Jones, J. P. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.058107 · Cited by 40
Effect of Structural Variation on Aldehyde Oxidase-Catalyzed Oxidation of Zoniporide
Dalvie, D., Sun, H., Xiang, C. D., Hu, Q., Jiang, Y., & Kang, P. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.045823 · Cited by 39
Foti, A., Hartmann, T., Coelho, C., Santos‐Silva, T., Romão, M. J., & Leimkühler, S. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.068395 · Cited by 39
Siah, M., Farzaei, M. H., Ashrafi-Kooshk, M. R., Adibi, H., Arab, S. S., Rashidi, M., & Khodarahmi, R. (2015) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2015.12.004 · Cited by 38
A Critical Review of Bioaccumulation and Biotransformation of Organic Chemicals in Birds
Kuo, D. T. F., Rattner, B. A., Marteinson, S. C., Letcher, R. J., Fernie, K. J., Treu, G., Deutsch, M., Johnson, M. S., Déglin, S. E., & Embry, M. R. (2022) · Reviews of Environmental Contamination and Toxicology · doi:10.1007/s44169-021-00007-1 · Cited by 37
Time Course of Aldehyde Oxidase and Why It Is Nonlinear
Abbasi, A., Paragas, E. M., Joswig-Jones, C. A., Rodgers, J. T., & Jones, J. P. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.085787 · Cited by 37
Choughule, K. V., Barr, J., & Jones, J. P. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.052985 · Cited by 35
Yang, X., Johnson, N., & Di, L. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.11.007 · Cited by 34
Rendić, S., Crouch, R. D., & Guengerich, F. P. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03304-3 · Cited by 37
Choughule, K. V., Joswig-Jones, C. A., & Jones, J. P. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.05.010 · Cited by 34
Crouch, R. D., Blobaum, A. L., Felts, A. S., Conn, P. J., & Lindsley, C. W. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.077552 · Cited by 33
Why Do Most Human Liver Cytosol Preparations Lack Xanthine Oxidase Activity?
Barr, J., Choughule, K. V., Nepal, S., Wong, T., Chaudhry, A. S., Joswig-Jones, C. A., Zientek, M. A., Strom, S. C., Schuetz, E. G., Thummel, K. E., et al. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.056374 · Cited by 30
Cytochrome P450 and Other Drug-Metabolizing Enzymes As Therapeutic Targets
Foti, R. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.001011 · Cited by 31
Identification of a suitable and selective inhibitor towards aldehyde oxidase catalyzed reactions
Nirogi, R. V. S., Kandikere, V. N., Palacharla, V. R. C., Bhyrapuneni, G., Kanamarlapudi, V. B., Ponnamaneni, R. K., & Manoharan, A. K. (2013) · Xenobiotica · doi:10.3109/00498254.2013.819594 · Cited by 30
Romão, M. J., Coelho, C., Santos‐Silva, T., Foti, A., Terao, M., Garattini, E., & Leimkühler, S. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.01.005 · Cited by 30
Self-citationBarsanti, P. A., Pan, Y., Lu, Y., Jain, R., Cox, M. O., Aversa, R. J., Dillon, M. P., Elling, R. A., Hu, C., Jin, X., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500352s · Cited by 29
The pharmacokinetics and safety of idelalisib in subjects with moderate or severe hepatic impairment
Jin, F., Robeson, M., Zhou, H., Hisoire, G., & Ramanathan, S. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.504 · Cited by 29
Marelja, Z., Dambowsky, M., Bolis, M., Georgiou, M. L., Garattini, E., Missirlis, F., & Leimkühler, S. (2014) · Journal of Experimental Biology · doi:10.1242/jeb.102129 · Cited by 28
Self-citationUse of Gold Nanoparticles as Additives in Protein Crystallization
Ribeiro, D. O., Kulakova, A., Quaresma, P., Pereira, E., Bonifácio, C., Romão, M. J., Franco, R., & Carvalho, A. L. (2013) · Crystal Growth & Design · doi:10.1021/cg4014398 · Cited by 29
An overview of aldehyde oxidase: an enzyme of emerging importance in novel drug discovery
Rashidi, M., & Soltani, S. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1284198 · Cited by 29
Not only tumor but also therapy heterogeneity
Garattini, S. K., Nerini, I. F., & D’Incalci, M. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx646 · Cited by 30
Species differences in metabolism of ripasudil (K-115) are attributed to aldehyde oxidase
Isobe, T., Ohta, M., Kaneko, Y., & Kawai, H. (2015) · Xenobiotica · doi:10.3109/00498254.2015.1096981 · Cited by 27
Foti, A., Dorendorf, F., & Leimkühler, S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0182061 · Cited by 26
Barr, J., Jones, J. P., Oberlies, N. H., & Paine, M. F. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.061192 · Cited by 26
Hutzler, J. M., Cerny, M. A., Yang, Y.-S., Asher, C. O., Wong, D. F., Frederick, K. S., & Gilpin, K. E. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.059030 · Cited by 26
Mota, C., Coelho, C., Leimkühler, S., Garattini, E., Terao, M., Santos‐Silva, T., & Romão, M. J. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.04.006 · Cited by 26
Self-citationStructure-based investigation of rat aldehyde oxidase inhibition by flavonoids
Hamzeh‐Mivehroud, M., Rahmani, S., Rashidi, M., Feizi, M. A. H., & Dastmalchi, S. (2013) · Xenobiotica · doi:10.3109/00498254.2012.755228 · Cited by 25
Atomic vacancies of molybdenum disulfide nanoparticles stimulate mitochondrial biogenesis
Singh, K. A., Soukar, J., Zulkifli, M., Kersey, A. L., Lokhande, G. K., Ghosh, S., Murali, A., Garza, N. M., Kaur, H. P., Keeney, J. N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52276-8 · Cited by 24
Öeren, M., Walton, P., Suri, J., Ponting, D. J., Hunt, P. A., & Segall, M. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01303 · Cited by 24
Fan, P. W., Zhang, D., Halladay, J. S., Driscoll, J. P., & Khojasteh, S. C. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.070169 · Cited by 24
Molybdenum-containing nitrite reductases: Spectroscopic characterization and redox mechanism
Wang, J., Keceli, G., Cao, R., Su, J., & Mi, Z. (2016) · Redox Report · doi:10.1080/13510002.2016.1206175 · Cited by 24
Obach, R. S., Prakash, C., & Kamel, A. M. (2012) · Xenobiotica · doi:10.3109/00498254.2012.683203 · Cited by 24
Gajula, S. N. R., Nathani, T. N., Patil, R. M., Talari, S., & Sonti, R. (2022) · Drug Metabolism Reviews · doi:10.1080/03602532.2022.2144879 · Cited by 23
Takaoka, N., Sanoh, S., Okuda, K., Kotake, Y., Sugahara, G., Yanagi, A., Ishida, Y., Tateno, C., Tayama, Y., Sugihara, K., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.04.017 · Cited by 23
Self-citationZdunek-Zastocka, E., & Sobczak, M. (2013) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2013.06.027 · Cited by 23
Mouse aldehyde-oxidase-4 controls diurnal rhythms, fat deposition and locomotor activity
Terao, M., Barzago, M. M., Kurosaki, M., Fratelli, M., Bolis, M., Borsotti, A., Bigini, P., Micotti, E., Carli, M., Invernizzi, R. W., et al. (2016) · Scientific Reports · doi:10.1038/srep30343 · Cited by 22
Self-citationNakagawa, T., Fowler, S. M., Takanashi, K., Youdim, K. A., Yamauchi, T., Kawashima, K., Sato-Nakai, M., Yu, L. J., & Ishigai, M. (2017) · Xenobiotica · doi:10.1080/00498254.2017.1344910 · Cited by 22
Janetka, J. W., Hopper, A. T., Yang, Z., Barks, J., Dhason, M. S., Wang, Q., & Sibley, L. D. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00419 · Cited by 22
Selective Heteroaryl N-Oxidation of Amine-Containing Molecules
Dyer, R. M. B., Hahn, P. L., & Hilinski, M. K. (2018) · Organic Letters · doi:10.1021/acs.orglett.8b00558 · Cited by 22
Cerqueira, N. M. F. S. A., Coelho, C., Brás, N. F., Fernandes, P. A., Garattini, E., Terao, M., Romão, M. J., & Ramos, M. J. (2014) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-014-1198-2 · Cited by 21
Self-citationCrouch, R. D., Morrison, R. D., Byers, F. W., Lindsley, C. W., Emmitte, K. A., & Daniels, J. S. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.068338 · Cited by 21
Aldehyde oxidase-dependent species difference in hepatic metabolism of fasudil to hydroxyfasudil
Mao, Z., Wu, Y., Li, Q., Wang, X., Liu, Y., & Di, X. (2017) · Xenobiotica · doi:10.1080/00498254.2017.1292016 · Cited by 21
Crouch, R. D., Hutzler, J. M., & Daniels, J. S. (2017) · Xenobiotica · doi:10.1080/00498254.2017.1296208 · Cited by 21
Transcriptome differences in frontal cortex between wild boar and domesticated pig
Long, K., Mao, K., Che, T., Zhang, J., Qiu, W., Wang, Y., Tang, Q., Ma, J., Li, M., & Li, X. (2018) · Animal Science Journal · doi:10.1111/asj.12999 · Cited by 21
Chiodi, D., & Ishihara, Y. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c03078 · Cited by 19
Kamimura, H., & Ito, S. (2015) · Xenobiotica · doi:10.3109/00498254.2015.1091113 · Cited by 19
N-Oxide Reduction of Quinoxaline-1,4-Dioxides Catalyzed by Porcine Aldehyde Oxidase SsAOX1
Mu, P., Zheng, M., Ming, X., Zheng, Y., Tang, X., Wang, Y., Wu, K., Chen, Q., Wang, L., & Deng, Y. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.055418 · Cited by 19
Tang, L. W. T., Shi, Y., Sharma, R., & Obach, R. S. (2024) · Drug Metabolism and Disposition · doi:10.1124/dmd.124.001802 · Cited by 18
Kamli, M. R., Kim, J., Pokharel, S., Jan, A. T., Lee, E. J., & Choi, I. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.06.126 · Cited by 18
Uehara, S., Yoneda, N., Higuchi, Y., Yamazaki, H., & Suemizu, H. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.091090 · Cited by 18
Uno, Y., Uehara, S., & Yamazaki, H. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114887 · Cited by 18
Minipig and Human Metabolism of Aldehyde Oxidase Substrates: In Vitro–In Vivo Comparisons
Wilkinson, D., Southall, R., Li, M., Wright, L. M., Corfield, L. J., Heeley, T. A., Bratby, B., Mannu, R., Johnson, S., Shaw, V. E., et al. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0087-3 · Cited by 17
Muta, K., Fukami, T., & Nakajima, M. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.09.016 · Cited by 17
Tang, L. W. T., DaSilva, E., Lapham, K., & Obach, R. S. (2024) · Drug Metabolism and Disposition · doi:10.1124/dmd.124.001693 · Cited by 16
Neurotoxic and cardiotoxic effects of pyrogallol on catfish (Clarias gariepinus)
Hamed, M., Martyniuk, C. J., Soliman, H. A. M., Osman, A. G. M., & Said, R. E. M. (2024) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2024.104481 · Cited by 16
Kücükgöze, G., Terao, M., Garattini, E., & Leimkühler, S. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.075937 · Cited by 16
Self-citationAntunes, M., Eggimann, F. K., Kittelmann, M., Lütz, S., Hanlon, S. P., Wirz, B., Bachler, T., & Winkler, M. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.03.045 · Cited by 15
Enzyme Kinetics, Inhibition, and Regioselectivity of Aldehyde Oxidase
Barr, J., Choughule, K. V., & Jones, J. P. (2014) · Methods in molecular biology · doi:10.1007/978-1-62703-758-7_9 · Cited by 15
Deen, C. P. J., van der Veen, A., Neto, A. W. G., Geleijnse, J. M., den Berg, K. J. B., Heiner-Fokkema, M. R., Kema, I. P., & Bakker, S. J. L. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020437 · Cited by 14
Metadata
- Authors
- Garattini, E., & Terao, M.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- Venue
- Expert Opinion on Drug Metabolism & Toxicology
- Publisher
- Informa UK Limited
- Published
- 2012-02-16
- Volume
- 8
- Issue
- 4
- Pages
- 487-503
- ISSN
- 1742-5255 (ISSN-L)
- 1744-7607
- OpenAlex
- W2156168853
- Cited by
- 174
- References
- 102
- Citations by year
- 2026: 10 · 2025: 7 · 2024: 8 · 2023: 8 · 2022: 9 · 2021: 16 · 2020: 8 · 2019: 8 · 2018: 18 · 2017: 19 · 2016: 12 · 2015: 14 · 2014: 16 · 2013: 9 · 2012: 12
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Opinion on Drug Metabolism & Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
- Keywords
- aldehyde oxidase, AOX1, drug metabolism, phase I metabolism, xenobiotic metabolism, aldehyde oxidation, cytochrome P450, hepatic clearance, substrate specificity
- MeSH terms
- Aldehydes, Alleles, Animals, Pharmaceutical Preparations, Humans, Isoenzymes, Species Specificity, Substrate Specificity, Xenobiotics, Aldehyde Oxidase, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review